Adimab, LLC 13D and 13G filings for Invivyd, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-29 4:15 pm Sale | 2025-12-23 | 13D | Invivyd, Inc. IVVD | Adimab, LLC | 20,262,170 7.300% | -192,320 (-0.94%) | Filing |
| 2025-11-19 4:30 pm Purchase | 2025-11-17 | 13D | Invivyd, Inc. IVVD | Adimab, LLC | 20,454,490 8.800% | 20,454,490 (New Position) | Filing |